| NDC Code | 43742-2261-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-2261-1) |
|---|
| Product NDC | 43742-2261 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Addiclenz |
|---|
| Non-Proprietary Name | Aspartame, Benzalkonium Chloride, Formalinum, Methylene Chloride, Methylparaben, Propylparaben, Sodium Benzoate, Sodium Citrate, Titanium Dioxide, Zincum Oxydatum, Arsenicum Album, Beta Vulgaris, Bisphenol A, Boldo, Chelidonium Majus, Cobaltum Metallicum, Cuprum Metallicum, Glyphosate, Iodium, Lycopodium Clavatum, Petroselinum Sativum, Phosphoricum Acidum, Selenium Metallicum, Taraxacum Officinale, Zincum Metallicum |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20250311 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | ASPARTAME; BENZALKONIUM CHLORIDE; FORMALDEHYDE SOLUTION; METHYLENE CHLORIDE; METHYLPARABEN; PROPYLPARABEN; SODIUM BENZOATE; SODIUM CITRATE, UNSPECIFIED FORM; TITANIUM DIOXIDE; ZINC OXIDE; ARSENIC TRIOXIDE; BETA VULGARIS WHOLE; BISPHENOL A; PEUMUS BOLDUS LEAF; CHELIDONIUM MAJUS WHOLE; COBALT; COPPER; GLYPHOSATE; IODINE; LYCOPODIUM CLAVATUM SPORE; PETROSELINUM CRISPUM WHOLE; PHOSPHORIC ACID; SELENIUM; TARAXACUM OFFICINALE; ZINC |
|---|
| Strength | 30; 30; 30; 30; 30; 30; 30; 30; 30; 30; 12; 3; 12; 3; 3; 12; 12; 12; 12; 12; 3; 12; 12; 3; 12 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
|---|
| Pharmacy Classes | Acidifying Activity [MoA], Allergens [CS], Allergens [CS], Allergens [CS], Ammonium Ion Binding Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Copper [CS], Copper-containing Intrauterine Device [EPC], Decreased Coagulation Factor Activity [PE], Decreased Copper Ion Absorption [PE], Decreased Embryonic Implantation [PE], Decreased Sperm Motility [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Inhibit Ovum Fertilization [PE], Nitrogen Binding Agent [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC] |
|---|